Drug Trials Snapshots: SYMDEKO

SYMDEKO is a drug for the treatment of cystic fibrosis (CF) in patients 12 years and older, who have specific gene mutations

Source: FDA Center for Drug Evaluation and Research - What's New - March 31, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news